ASMB
Assembly Biosciences Inc
23.70$
+0.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +166.3% | -12.8% | -3.8% | -13.1% | +18.9% | -16.9% | -18.4% | +197.1% | +7.3% | -8.6% | +40.5% | |
| – | +169.3% | -12.4% | -3.6% | -13.0% | +17.6% | -17.3% | -18.9% | +205.7% | +7.5% | -8.6% | +41.0% | |
| – | -25.6% | -5.5% | +2.4% | +48.1% | +34.8% | -38.9% | +2.5% | -6.1% | +159.4% | -46.8% | +3.7% | |
| – | +181.9% | -13.3% | -3.3% | -13.1% | +18.0% | -18.8% | -17.6% | +210.2% | +6.7% | -8.7% | +41.4% | |
| – | -57.0% | +0.0% | +830.2% | -100.0% | – | +0.0% | -25.0% | +204.0% | +6.8% | -53.7% | +82.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +872.0% | -9.4% | -7.6% | -7.9% | +15.6% | -16.2% | -12.8% | -8.6% | -11.3% | -27.4% | -31.7% | |
| – | +450.0% | -1.2% | +6.5% | +0.9% | +14.8% | -2.5% | +1.4% | +12.9% | -8.6% | -28.3% | -33.0% | |
| – | +40.4% | -6.1% | +13.1% | +2.6% | -65.3% | +14.8% | +0.8% | +2.8% | +3.8% | +3.7% | +3.7% | |
| – | -39.2% | +57.7% | +10.2% | +66.7% | -56.2% | +49.6% | -15.1% | +126.5% | -30.4% | -3.6% | +4.5% | |
| – | -1.5% | -20.7% | +6.4% | -25.0% | +28.3% | -18.7% | -33.3% | +909.4% | +13.2% | -3.9% | +53.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +25.2% | +0.0% | +2.9% | +12.6% | +3.6% | +14.1% | +2.0% | +0.0% | +46.4% | +50.7% | +11.6% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.